1. A. Barzilai, G. Keren, N. Keller, E. Rubinstein.
Pharmacokinetics and therapeutic efficacy of ciprofloxacin in an experimental
pleural empyema model in rabbit.
Rev. Inf. Dis.vol 105 pp.123 - 124 1988.
2. B.P. Overbeek, N.M. De Vos, N. Keller, G. Raponi, M. Rozenberg- Arska, J
Verhoef.
Enhanced binding of monoclonal antibodies to lipopplysaccharide structure of
enterobacteriaceae after treatment with antibiotics.
Serodiagn . immunother infect Dis,vol 3 pp 164-173, 1989.
3. N. Keller, G. Raponi, I. M.Hoepelman, M. Rozenberg- Arska. J. Verhoef.
Effect of inhibitory concentration of ciprofloxacin and fleroxacin on the
opsonization and phagocytosis of bacteria.
Rev. Inf. Dis, suppl 5:1064,1989.
4. G. Raponi, R. W. Vreeds, Rozenberg- Arska, I.M. Hoepelman, N. Keller, J.
verhoef. The influence of subminimal inhibitory concentration of netimyxin
and ceftriaxone on the interaction of Escherichia coli with host defences.
Jour of antimicrobial chemotherapy vol 23, pp546-565, 1990.
5. G. Raponi, N. Keller, M.Rozenberg- Arska I.M. Hoepelman, J. Verhoef.
The influence of cepepime on opsonophagocytosis of bacteria.
Drug Exptl Clin Res, Vol 15(4),pp 141-144, 1989.
6. N. Keller, G. Raponi, I.M. Hoepelman, B. P. Overbeek, M. Rozenberg- Arska,
J. Verhoef.
Effect of subminimal inhibitory concentration of ciprofloxacin and fleroxacin
on the bacterial capsular antigen and opsonophagocytosis by human
polymorphonuclear leukocytes.
Int J Med Microbiol, vol 274(4), pp 519-526, 1991.
7. N. Keller, J. Rosenblum, h. Haklay, C.S. Block.
A computerized databank- a tool for monitoring antibiotic sensitivity pattern
in a large
medical center. The Israel society of medical data bulletion. Vol 6 pp78-79,
1991.
8. G.Raponi, N. Keller, BP Overbeek, M. Rozenberg-Arska, KPM Van Kessel, J.
Verhoef. Enhanced phagocytosis of encapsulated E. coli strains after
exposures to Sub-mic of antibiotics is correlated to changes of the bacterial
cell surface.
Antimicrobial agent and chemotherapy, Vol 34(2), pp332-336, 1990
9. G.Raponi N. Keller BP. overbeek, M. Rozenberg- Arska, R. Torensma, J.
verhoef. Immunization of mice with antibiotic treated bacteria E. coli results
in enhanced protection against challeng with homologous and hetrologous
bacteria.
The journal of infectious diseases Vol 163(1), pp 121-124, 1991.
10. Raponi, N. Keller, M. Rozenberg-Arska, M. Terasa Lun, C.Mancini, J.
Verhoef.
Tumor necrosis factor alpha (TNF-a) production in mice immunised with
Escherichia coli: Correlation with mortality after lethal challenge and
production of native inhibitor of TNF-a activity.
Infection and immunity vo161 pp 3876-3980,1993.
11. G. Raponi , N. Keller, A. Massini. .A Gaeta, N. Bafini, R.A. Deblasi, G.
Conti,
R.R. E`Errico, D. Mancini, F. Filaduro, A. Gasparette, Tumour necrosis factor
in bronchoalveolar lavage of patients at risk for the adult respiratory distress
syndrome.
Journal of critical care, vol 7, 183-188, 1992.
12. J. Yahav, G. Oderda, A. Diver-Haber, N. Keller, A. Jonas. Mucosal peptic
activity during Helicobavter pylori infection in paeditric patients.
Gut, Vol 39(9), pp 1162-1165, 1992.
13. C. Block, Y. Davidson, E. Melamed, N. Keller, Susceptibility of Neisseria
meningitidis in Israel to penicillin and other drug of interest.
J. Antimicrob Chemother, Vol 32,pp 166-168, 1993.
14. N. Lindner, R. Dagan, J. Kuint, N. Keller, G.Keren, B. Reichman.
Ventriculis caused by Klebsiella pneumonia carfully reaed wih pefloxacin in a
neonae.
Infection Vol 22, 1994.
15. R. Mamet, R. Scharf, N. Keller, Y. Zimmel, N. Schoenfeld. Determination of
coporphirinogen III oxidase activity in bacteria.
Journal of microbiological methods 1994.
16. S. Schulman, D. Varon, N. Keller, S. Gitel, U. Martinowitz. Monoclonal
purified F IIIa continous infusion: Stability, Microbiological safety, and
clinical experience.
Thrombosis and haemostasis 12(3), 403-407, 1994.
17. R. Frilling, P. Yagupky, N. Keller.
Corneal ulcer in a child caused by Nocardia asteroides following corneal
perforation. Ped Inf Dis Jour, 1995
18. S. Shihab, A. Barkay, N. Keller, L. Leitner, A. Leventhal.
A program of large scale mass prophylaxis against Neisseria meningitides in
two Arab villages.
Public healh review vol 23, pp-373-374, 1995.
19. S. Schulman, M. Bech-Jensen, D. Varon, N. Keller, S. Gitel, H. Horoszowski,
M.
Heim, U. Martinowitz.
Feasibility and of using recombinant factor VIIa in contintous infusion.
Thrombosis and haemostasis, Vol 75(3), pp 432-436, 1996.
20. E. Rubinstein, N. Keller.
Future prospect and therapeuics potential in streptogramins.
Drugs vol 51,pp 27-31, 1996.
21. P. Raanani, M. Thaler, N. Keller, I. Ben-Bassat.
Cutaneous Mycobacterium Kansasii infection in a patient with hairy cell
leukemia afer treatment with 2- chiordeoxyadenosine.
Postgrad Med J 1997:43.
22. Yahav J., Ordea G., Diver-Haber A., Fradkin A., N. Keller., Altare F.,
Amsaldi N., Jonas A.
Serum pepsinogen I in childhood Helicobacter pylori gastritia: ita relation to
mucosal peptic activity.
Isr J Med Sci 1996 Jan; 32 (1): 56-9.
23. Salai M., Rotstein Z., N. Keller.
[Bone Bank - operational and professional aspects in the orthopedic
community in Israel]
Harefuah 1996 Mar 16; 132 (6): 410-1.
24. Orenstein A., Klein D., Kopolovic J., Winkler E., Malik Z., N. Keller., Nitzan
Y.
The use of porphyrins for eradication of Staphylococus aureus in burn wound
infection.
F E M S Immunol Med Microbiol 1997 Dec; 19(4): 307-14.
25. Linder N., N. Keller., Huri C., Kuint J., Goldschmidt-Reuven A., Barzilai
A.
Primary cutaneous mucormyiosis in a premature infant: case report and a
review of the literature.
Am J Peritanol 1998 Jan; 15 (1): 35-8
26. Block Cs., Davidson Y., N. Keller.
Unreliability of Disc Diffusion. Test for screening for reduced penicillin
susceptibility in Neisseria meningitides.
J C M 1998 36:3103-3104
27. Rubinstein E., N. Keller.
Spiramycin renaissance.
JAC 1998 45:572-576
28. Assie E.I., Jarban R.Z., Solberg Y., N. Keller.
The role of Interoccular lenses in Anterior Chamber Contamination During
Cataract Sugery.
Graef’s Arch Clin Exp Ophtalmol 1998 Oct;236(10):721-4.
29. Amir J. Ginat S., Coehn H., Ideling T., N. Keller., Versane I.,
Lidocin as a Diluent for Administration of Benzathine Penicillin G
Ped. Inf Dis J 1998 Oct;17(10);890-893
30. Barzili A. Rubinovitch B. Blank-porat D. Rubinstein E. N. Keller. Levi I.
Successful treatment of disseminated Mycobacterium simiae infection in
AIDS patient. Scand J Infect Dis 1998;30(2)143-6
31. Dagan R. Frazer D. Greif Z. N. Keller. Kaufstein M. ,Schazberg G.,
Schelezinger M.
A nationwide prospective surveillance study in Israel to document pediatrics
invasive infections with an emphasis on Haemophilus influenzae type B
infections. Israeli pediatric and bacteria and meningitis group.
Ped Infect Dis J. 1998 Sep;17(9Suppl):S198-203
32. Shehab S., N. Keller., Barkay A., Leitner I., Leventhal A., Block C.
Failure of mass chemoprophylaxis to intercept a prolonged outbreak of
meningococcal disease in an Israeli Village.
Europ J of Clin Microbil Infect Dis 1998;17(11):749-753
33. R. Neeman, N. Keller, A. Barzilai, Z. Korenman, S. Sela. Prevalence of the
internalization- associated gene prtF1, among persisting group A
streptococcus
strains from asymptomatic carriers. Lancet 1998:352:1974-1977
34. J. Waksman, D. Huminer, N. Keller, S.D. Pitlik.
Delayed synchronous outbreak of plasmodium vivax malaia in four travelers.
Jour of travel medicine 1999:6;
35. Block C., Gdalevich M., Buber R., Ashkenazi I., Ashkenazi S., N. Keller.
Factors associated with pharyngeal carriage of Neisseria Meningitidis among
Israel Defence Force personnel at the end of their compulsory service.
Epidemiology and infection 1999, 122,51-57
36. N. Keller, G. Smollen, Y. Davidson, A. Barzilai, G. Keren, E. Rubinstein
The susceptibility of Streptococcus pneumonia to Levofloxacin and other
antibiotic drugs. JAC 1999:43;supll,C1-3
37. ‫הרגישות והעמידות של חיידק הליקובקטר פילורי לטפול אנטיביוטי בישראל‬
3:::93179474-472 ‫ קלר הרפואה‬.‫ נ‬,‫ בר מאיר‬.‫ ש‬,‫ יונש‬.‫ א‬,‫ חוברס‬.‫ י‬,‫ וויס‬.‫ ב‬,‫ אבידן‬.‫ב‬
Translation here:
38. M. Y. Chowers, * R. Tal, I. Barshack, R. Lang, S. Bar-Meir, Y. Chowers.
Human Gastrin: A Helicobacter pylori-Specific Growth Factor.
Gastroenterology;117:1113-1118
39. Paret G., N. Keller., Barzilai A., Zemach M., Guttman D.,Vardi A., Shtzberg
G., Cohen H., and Z. Barzilay.
Invasive meningococcal disease: Patient and strain characteristics set new
challenge for prevention and control
Infection 1999:27:4-5:261-264
40. M. Salai, T. Brosh, N. Keller, M. Perelman, I. Dudkiewitz
The effects of prolonged cryoprerservation on the biomechanical properties of
bone allografts: A microbiological, histological and mechanical study.
Cell and Tissue Banking 2000 (1):69-73
41. Y. Kreiss, Z. Vered, N. Keller, I. Kochva, Y. Sidi H. Gur.
Aspergillus niger endocarditis in an immunocompetent patient: an Unusual
course. Post graduate Med J. 76:105-106;2000
42. Blank M, Krause I, Fridkine M, N. Keller, Shoenfeld Y.
Molecular mimicry: lessons from an experimental model of antiphospholipid
syndrome in naive mice.
Isr Med Assoc J. 2000 Dec;2 Suppl:20-1.
43. Low DE, N. Keller, Barth A, Jones RN.
Clinical prevalence, antimicrobial susceptibility, and geographic resistance
patterns of enterococci: results from the sentry antimicrobial surveillance
program, 1997-1999.
Clin Infect Dis. 2001 May 15;32 Suppl 2:S133-45.
44. Avidan B, Melzer E, N. Keller, Bar-Meir S.
The effect of culture results for Helicobacter pylori on the choice of treatment
following failure of initial eradication.
Isr Med Assoc J. 2001 Mar;3(3):163-5.
PMID: 11303370
45. Rubinstein E, Diamantstein L, Yoseph G, Gruzman G, Rubinovitch B,
Barzilai A,
N. Keller.
The effect of albumin, globulin, pus and dead bacteria in aerobic and
anaerobic conditions on the antibacterial activity of moxifloxacin,
trovafloxacin and ciprofloxacin against Streptococcus pneumoniae,
Staphylococcus aureus and Escherichia coli.
Clin Microbiol Infect. 2000 Dec;6(12):678-81. PMID: 11284929
46. Lotan D, Zilberman D, Dagan O, N. Keller, Ben-Abraham R, Weinbroum AA,
Harel R, Barzilay Z, Paret G.
Beta-chemokine secretion patterns in relation to clinical course and outcome
in children after cardiopulmonary bypass: continuing the search to abrogate
systemic inflammatory response.
Ann Thorac Surg. 2001 Jan;71(1):233-7. PMID: 11216753
47. Grisaru-Soen G, Lerner-Geva L, N. Keller, Berger H, Passwell JH, Barzilai A.
Pseudomonas aeruginosa bacteremia in children: analysis of trends in
prevalence, antibiotic resistance and prognostic factors.
Pediatr Infect Dis J. 2000 Oct;19(10):959-63. PMID: 11055596
48. Paret G, Prince T, N. Keller, Dagan O, Sasson Y, Barzilai A, Guthmann D,
Barzilay Z.
Plasma-soluble E-selectin after cardiopulmonary bypass in children: is it a
marker of the postoperative course?
J Cardiothorac Vasc Anesth. 2000 Aug;14(4):433-7. PMID: 10972611
49. Grisaru-Soen G, Goldman R, Barzilai A, Lotan D, N. Keller.
False-positive urine cultures using bag collection.
Clin Pediatr (Phila). 2000 Aug;39(8):499-500. No abstract available. PMID:
10961824
50. Wysenbeek YS, Blank-Porat D, Harizman N, Wygnanski-Jaffe T, N. Keller,
Avni
I. The reculture technique: individualizing the treatment of Acanthamoeba
keratitis.
Cornea. 2000 Jul;19(4):464-7.PMID: 10928758
51. Talmi YP, Knoller N, Dolev M, Wolf M, Simansky DA, N. Keller, Hadani M,
Ohry A, Kronenberg J.
Postsurgical prevertebral abscess of the cervical spine.
Laryngoscope. 2000 Jul;110(7):1137-41. PMID: 10892684
52. Paret G, N. Keller, Barzilai A, Zemach M, Guttman D, Vardi A, Shatzberg G,
Cohen H, Barzilay Z.
Invasive meningococcal disease: patient and strain characteristics set new
challenge for prevention and control.
Infection. 1999;27(4-5):261-4. PMID: 10885839
53. Blank M. Krauze I. Fridkine M. N. Keller. Shoenfeld Y.
Molecular mimicry: lesson from an experimental model of antiphospholipid
syndrome in naïve mice
Isr Med Assoc J. 2000, Dec;2 suppl 20-1
54. S. Sela, R. Neeman, N. Keller, A. Barzilai
Relationship between asymptomatic carriage of the Streptococcus pyogenes
and the ability of the strains to adhere to and be internalised by cultured
epithelial cells.
J. Med. Microbiol 2000 49:499-502
55. Lotan D. Prince T. Dagan O. N. Keller. Ben Avraham R. Weinbrroum A.
Gaby A. Augarten A. Smolinski A. Barzilai Z. Paret G.
Soluble P-selectin and the postoperative course following cardiopulmonary
bypass in children.
Paed Anaesth. 2001 may;11(3):303-8
56. Talmi Y.P., Goldschmied-Reuven A., Bakon M. Bareshak I., Wolf M.,
Horowitz, Berkowicz M, N. Keller., Kronenberg J.
Rhino-orbital and Rhino-orbito-cerebral mucormucosis.
Otolaryng, head and neck surgery 2001 :127(1);22-30
57. Blank M. Krauze I. Fridkine M. N. Keller .Kopolovic J. Goldberg I. Tobar A.
Shoenfeld Y,
Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the
infections etiology of antiphospholipid syndrome.
Jour of clinical investigation 2002;109(6);797-804
58. Lubetsky A. Martinovits U. Luboshitz J. Kenet G. N. Keller. Tamarin I. Inbal
A.
Efficacy and safety of a factor VIII – von Willerband factor concentration 8Y ;
stability, bacteriological safety, pharmacokinetic analysis and clinical
experience.
Haemophilia; 2002,8'622-628
59. Dagan O. Prince T. Ben Avraham R. Vidne B. Mishali D, Katz Y , N. Keller.
Barzilay Z. Paret G. .
Soluble L-selectin and the postoperative course following cardiopulmonary
bypass in children.
Med Sci Monit 2002;8(7):CR467-472
60. L. Shlush D. M. Behar A. Zelazny, N. Keller, Lupsky J.R. Beaudet A.L. and
Bercovich D.
Molecular epidemiological analysis of the changing nature of a meningococcal
outbreak following a vaccination campaign.
Jour of clin Microb 2002;40(10);3565-3571.
61. Chowers MY, N. Keller, Bar-Meir S, Chowers Y.
A defined human gastrin sequence stimulates the growth of Helicobacter
pylori.
FEMS Microbiol Lett. 2002 Dec 17;217(2):231-6
62. Ben-Abraham R, N. Keller, Szold O, Vardi A, Weinberg M, Barzilay Z, Paret
G.
Do isolation rooms reduce the rate of nosocomial infections in the pediatric
intensive care unit?
J Crit Care. 2002 Sep;17(3):176-80
63. Talmi YP, Goldschmied-Reouven A, Bakon M, Barshack I, Wolf M,
Horowitz Z, Berkowicz M, N. Keller, Kronenberg J.
Rhino-orbital and rhino-orbito-cerebral mucormycosis.
Otolaryngol Head Neck Surg. 2002 Jul;127(1):22-31.
64. Siegman-Igra Y, Levin R, Weinberger M, Golan Y, Schwartz D, Samra Z,
Konigsberger H, Yinnon A, Rahav G, N. Keller, Bisharat N, Karpuch J,
Finkelstein R, Alkan M, Landau Z, Novikov J, Hassin D, Rudnicki C, Kitzes
R, Ovadia S, Shimoni Z, Lang R, Shohat T.
Listeria monocytogenes infection in Israel and review of cases worldwide.
Emerg Infect Dis. 2002 Mar;8(3):305-10
65. Ben-Abraham R, N. Keller, Vered R, Harel R, Barzilay Z, Paret G.
Invasive group A streptococcal infections in a large tertiary center:
epidemiology, characteristics and outcome.
Infection. 2002 Apr;30(2):81-5.
66. Efrati O, Barak A, Yahav J, Leibowitz L, N. Keller, Bujanover Y.
Primary meningococcal arthritis.
Isr Med Assoc J. 2002 May;4(5):386-7
67. O. Dagan O, T. Prince T, R. Ben-Abraham R, B. Vidne B, D. Mishaly D, Y.
Katz Y, N. Keller, Z. Barzilay Z, Paret G.
Plasma soluble L-selectin following cardiopulmonary bypass (CPB) in
children: is it a marker of the postoperative course?
Med Sci Monit. 2002 Jul;8(7):CR467-72.
68. R. Ben-Abraham, N. Keller, N. Teodorovitch, A. Barzilai, R. Harel, Z.
Barzilay, G. Paret
Predictors of adverse outcome from candidal infection in a tertiary care
hospital.
J of Infect 2004 49:317-323
69. Regev – Yochay G, Raz M, Dagan R, Porat N, Shainberg B, Pinco E, Keller
N, Rubinstein E. Nasopharyngeal carriage of streptococcus pneumoniae by
adults and children in community and family settings. Clin Infect Dis. 2004;
Mar 1;38(5): 632-9
70. J. Strahilevitz, G. Rhav, HJ Schroers, R.C. Summerbell, Z. Amitai, A
Goldschmied-Reouven, E. Rubinstein, Y. Schwammenthal, M. S. Feinberg, Y.
Siegman-Igra, E. Bash, I. Polachek, A. Zelazny, S. J. Howard, P. Cibotaro, O.
Shovman, N. Keller
An Outbreak of Phialemonium Infective Endocarditis Linked to
INtracavernous Penile Injections for the Treatment of Impotence.
CID 2005; 40
71. Grisaru-Soen G, Wysoki MG, Keller N, Risk factors for development of nontyphoid Salmonella bacteremia. Clin Pediatr (Phila). 2004 Nov-Dec
;43(9):825-9
72. M. Weinberger, N. Keller
Recent trends in the epidemiology of non-typhoid Salmonella and
antimocrobial resistance:the Israeli experience and worldwide review.
Curr Opin Infect Dis, 2005 18:513-521
73. Nir-Paz R, Strahilevitz J, Shapiro M, Keller N, Goldschmied-Reuven A,
Yarden O, Block C, Polacheck I. Clinical and epidemiological aspects of
infections caused by fusarium species. J Clin Microbiol, 2004.
Aug;42(8):3456-61
74. Linder N, Prince S, Barzilai A, Keller N, Klinger G, Shalit I, Prince T, Sirota
L, Disinfection with 10% povidone-Iodine versus 0.5% chlorhexidine
gluconatein 70% sospropanol in the neonatal intensive care unit, Acta
paediatr. 2004 Feb;93(2):205-10
75. T. Shpitzer, N. Keller, M. Wolf, A. Goldschmied-Reouven, G. Bahar, I.
Bahar, J. Kronenberg, R. Feinmesser, Y.P. Talmi.
Seasonal Variations in Rhino-cerebral Mucor Infection.
Ann. Otology, Rhinol Laryngol, 2005 114(9)695-698
76. M. Weinberger, L. Leibovici, S. Perez, Z. Samra, I. Ostfeld, I. Levi, E. Bash,
D. Turnery, A. Goldschmied-Reouven, G. Regev-Yochay, S. D. Pitlik, N.
Keller.
Characteristics of candidaemia with Candida-albicans compared with nonalbicans Candida species and predictors of mortality.
Journal of Hospital Infection, 2005 61:146-154
77. M. Weinbereger, I. Mahrshak, N. Keller, A. Goldscmied-Reuven, N.
Amariglio, M. Kramer, A. Tobar, Z. Samras, S.D. Pitlik, M.G. Rinaldi, E.
Thompson, D. Sutton
Isolated endogenous endophthalmitis due to a sporodochial-forming
Phialemonium curvatum acquired through intracavernous autoinjections.
Medical Mycology, 2006 44:253-259
78. G. Rahav, S. Pitlik, M. Scheflan, Z. Amitai, A. Lavy, M. Blech, N. Keller, Y.
Davidson,, A. Zlotkin.
An outbreak of “Mycobacterium jacuzzii” infection following prosthetic breast
implants caused by skin colonization of the surgeon.
Clin. Infect. Dis., 2006 Oct 1;43(7):823-830
79. Aisenkraft, Il Keidan, B. Bielorai, N. Keller, G. Paret
MCP-1 in the cerebrospianl fluid of children with acute lymphoblastic
leukemia.
Leukemia Research, 2006 30(10):1259-1261
80. T. Hasin, N. Davidovitch, R. Cohen, T. Dagan, A. Romem, N. Orr, E.
Klement, N. Lubetsky, R. Kayouf, T. Sela, N. Keller, E. Derazne, T. Halperin,
M. Yavzori, I. Grotto, D. Cohen.
Post Exposure Treatment with Doxycycline for the Prevention of Relapsing
Fever.
N Engl J of Med, 2006 13;355(2):148-155
81. J. Kuint, A. Barzilai, G. Regev-Yochay, E. Rubinstein, N. Keller, A. Maayan,
Comparison of community-acquired Methicillin-Resistant Styaphylococcus
aureus bacteremia to other Staphylococcal species in a Neonatal Intensive
Care Unit.
European J of Pediatrics. 2006 166(4):319-325.
82. R. Colodner, Z. Samra, N. Keller, H. Sprecher, C. Block, N. Peled, T.
Lazarovitch, R. Bardenstein, O. Schwartz-Harari, Y. Carmeli, Israel ESBL
Group.
First National Surveillance of In-Vitro Susceptibility of Extended-Spectrum
Beta-Lactamase Producing E. coli and Klebsiella spp in Israel. Diagn.
Microbiol. Infect. Dis. 2007. 57(2):201-205.
83. Y. Maor, G. Rahav, N. Belausov, D. Ben-David, G. Smollan, N. Keller.
Prevalence and characteristics of Heteroresistant Vancomycin-Intermediate
Staphylococcus aureus (hVISA) Bacteremia in a Tertiary Care Center.
Journal of Clinical Microbiology. J Clin Microbiol. 2007 May;45(5):1511-4.
Epub 2007 Mar 7.
84. Y. Chowers, J. Kirschner, N. Keller, I. Barshack, S. Bar Meir, S. Ashkenazi,
R. Schneerson, J. Robbins, J. Passwell.
Specific polysaccharide conjugate vaccine-induced IgG antibodies prevent
invasion of Shigella into Caco-2 cells and may be curative. PNAS 2007.
104(7): 2396-2401.
85. Hindiyeh M, Keller N, Mandelboim M, Ram D, Rubinov J, Regev L, Levy V,
Orzitzer S, Shaharabani H, Azar R, Mendelson E, Grossman Z. High Rate of
Human Bocavirus and Adenovirus Co-infection in Hospitalized Israeli
Children J Clin Microbiol. 2007 Oct 31
86. Grisaru-Soen G, Sweed Y, Lerner-Geva L, Hirsh-Yechezkel G, Boyko V,
Vardi A, Keller N, Barzilay Z, Paret G. Nosocomial bloodstream infections in
a pediatric intensive care unit: 3-year survey Med Sci Monit. 2007
Jun;13(6):CR251-7.
87. Bilavsky E, Eliahou R, Keller N, Yarden-Bilavsky H, Harel L, Amir J Effect
of benzathine penicillin treatment on antibiotic susceptibility of viridans
streptococci in oral flora of patients receiving secondary prophylaxis after
rheumatic fever J Infect. 2008 Apr;56(4):244-8. Epub 2008 Mar 4
88. Barequet IS, Habot-Wilner Z, Keller N, Smollan G, Ziv H, Belkin M, Rosner
MEffect of amniotic membrane transplantation on the healing of bacterial
keratitis Invest Ophthalmol Vis Sci. 2008 Jan;49(1):163-7
89. M. Hindiyeh., Smollen G., Grossman Z., Ram D., Davidson Y., Mileguir F.,
Vax M., Ben David D., Tal I., Rahav G., Mendelson E., Keller N., Rapid
detection of blaKPC carbapenamase genes by Real-Time PCR J. Clin.
Microbiol. 0: JCM.00661-08v1
90. Maor y., Hagin M., Belausov N., Keller N., Ben David D., Rahav G.,
Clinical features of heteroresistant vancomycin – Intermediate
Staphylococcus aureus bacteremia compared to methicillin resistant
Staphylococcus aureus bacteremia. Journal of infectious diseases 2009
Mars 1:199 (5) 619-24
91.
92. Ashkenazi-Hoffnung L, Kaufman Z, Bromberg M, Block C, Keller N, Dictar
R, Goldberg A, Green MS Se implications. Seasonality of Bacillus species
isolated from blood cultures and its potential Am J Infect Control. 2009 Jan
20.
93. Strahilevitz J, Adler A, Smollan G, Temper V, Keller N, Block C. Serogroup
A Neisseria meningitidis with reduced susceptibility to ciprofloxacin. Emerg
Infect Dis. 2008 Oct;14(10):1667-9.
94. Association of Cardiologists of Israel; Association of Circulatory Diseases of
Israel; Israel Dental Association; Division of Quality Control, Scientific
Committee, Israel Medical Association, Gilon D, Zigman-Igra Y, Metzki S,
Basra J, Shiran A, Keller N, Levi E, Litner M [Guidelines for prevention of
infective endocarditis] Refuat Hapeh Vehashinayim. 2008 Jan;25(1):59-66.
95. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Bijie H, Dzierzanowska D,
Klimko NN, Letscher-Bru V, Lisalova M, Muehlethaler K, Rennison C, Zaidi
M; Global Antifungal Surveillance Group. Results from the ARTEMIS DISK
Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of
susceptibilities of noncandidal yeast species to fluconazole and voriconazole
determined by CLSI standardized disk diffusion testing.J Clin Microbiol. 2009
Jan;47(1):117-23
96. Maor y., Lago A., Zlotkin A.,Nitzan Y.,, Belausov N., Keller N .,Rahav
G., Molecular features of heteroresistant vancomycin - intermediate
Staphylococcus aureus strains isolated from bacteremic patients BMC
Microbiol, 2009;Sept;9(1):189
97. Maayan – Metzger A, Barzilai A, Keller N, Quint J Are the " good old"
Antibiotics still appropriate for the early onset neonatal sepsis? A 10 years
survey.Isr Med Assoc J. 2009 Mar;11(3):138-42.
98. A.M. Whitney, G.B. Coulson, A. Von Gottberg, C. Block, N. Keller,
L.W. Mayere, N.E. Messonnier, K.P. Klugman, Genotypic comparison
of Neisseria meningitidis serogroup Y isolates from the United States,
South Africa , and Israel, 1999-2002 ; Journal of Clinical Microbiology
99. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolcar S,
Diekma Dj, ARTEMIS DISK global antifungal surveillance program
Diagn Microbiol infect dis. 2009. Sep; 65(1):27-34.
100.
Regev-Yochay G, Raz M, Carmeli, shainberg B, Navon-venezia
S, Pinco E, Leavitt A Keller N, Rahav G, malley R, Rubinstein E, The
Maccaci implementating Judicious antibiotic prescription study group,
Parental Staphylococcus aureus carriage is associated with staphylococcal
carriage in young children. Ped Inf Dis Jour 2009 Sept;
101.
.Shouval DS, Porat N,Dagan R, Keller N, Bilavsky E, Sivan Y,
Amir J, Bateremia caused by a highly resistant Streptococcus pneumonia
serotype 19A circulating in a daycare center.Int. J. inf. Dis. 2010 Feb 4
102.
Ben-David D, Maor Y, Keller N, Regev-Yochay G, Tal I, Shachar
D, Zlotkin A, Smollan G, Rahav G. Potential Role of Active Surveillance
in the Control of a Hospital-Wide Outbreak of Carbapenem-Resistant
Klebsiella pneumoniae Infection. Infect Control Hosp Epidemiol. 2010
Apr 6.
103.
Mann T, Ben-David D, Zlotkin A, Shachar D, Keller N, Toren A,
Nagler A, Smollan G, Barzilai A, Rahav G. An outbreak of Burkholderia
cenocepacia bacteremia in immunocompromised oncology patients.
Infection. 2010 Apr
104.
Yeshuron M., Gefter-Gvili A., Thaler M., Keller N., Nagler A.,
Shimoni A. Clinical characteristic of Stenotrophomonas maltophillia. In
hematopoeitic stem cell transplantation reciepient a single center
experience Infection 2010 Apr 28